Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (221-230 of 1,124) with videos related to

Pageof 113
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2009
Diagnosis and management of benign prostatic hyperplasia in primary careSimon Tanguay, Murray Awde, Gerald Brock, et al.
Frontiers in Oncology|June 2, 2012
Influence of pH on the Cytotoxic Activity of Inositol Hexakisphosphate (IP6) in Prostate CancerBlandine Betton, Philippe O Gannon, Ismaël Hervé Koumakpayi, et al.
Future Oncology (London, England)|March 25, 2025
Prostate-specific antigen (PSA) response with darolutamide in metastatic hormone-sensitive prostate cancer and its impact on treatment outcomes in the ARASENS trial: a plain language summaryFred Saad, Maha H A Hussain, Bertrand Tombal, et al.
Histopathology|August 19, 2010
A novel method of cell embedding for tissue microarraysMagdalena Zietarska, Jason Madore, Jean-Simon Diallo, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 24, 2025
Optimizing therapy for high-risk biochemically recurrent non-metastatic prostate cancer: Current and emerging strategiesChristian Kollmannsberger, Antonio Finelli, Andrew Loblaw, et al.
The Journal of Urology|February 26, 2008
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomyShahrokh F Shariat, Jochen Walz, Claus G Roehrborn, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
<i>Supplementary data:</i> Maximal testosterone suppression in the management of recurrent and metastatic prostate cancerLaurence Klotz, Rodney H Breau, Loretta L Collins, et al.
European Urology|June 30, 2009
Castration-resistant prostate cancer: from new pathophysiology to new treatment targetsKim N Chi, Anders Bjartell, David Dearnaley, et al.
Cellular Signalling|February 13, 2007
NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cellsLaurent Lessard, Fred Saad, Cécile Le Page, et al.
The Prostate|January 27, 2009
Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell linesBenjamin Péant, Jean-Simon Diallo, Florent Dufour, et al.
Pageof 113

Showing results (221-230 of 1,124) with videos related to

Sort By:
Pageof 113
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2009
Diagnosis and management of benign prostatic hyperplasia in primary careSimon Tanguay, Murray Awde, Gerald Brock, et al.
Frontiers in Oncology|June 2, 2012
Influence of pH on the Cytotoxic Activity of Inositol Hexakisphosphate (IP6) in Prostate CancerBlandine Betton, Philippe O Gannon, Ismaël Hervé Koumakpayi, et al.
Future Oncology (London, England)|March 25, 2025
Prostate-specific antigen (PSA) response with darolutamide in metastatic hormone-sensitive prostate cancer and its impact on treatment outcomes in the ARASENS trial: a plain language summaryFred Saad, Maha H A Hussain, Bertrand Tombal, et al.
Histopathology|August 19, 2010
A novel method of cell embedding for tissue microarraysMagdalena Zietarska, Jason Madore, Jean-Simon Diallo, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 24, 2025
Optimizing therapy for high-risk biochemically recurrent non-metastatic prostate cancer: Current and emerging strategiesChristian Kollmannsberger, Antonio Finelli, Andrew Loblaw, et al.
The Journal of Urology|February 26, 2008
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomyShahrokh F Shariat, Jochen Walz, Claus G Roehrborn, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
<i>Supplementary data:</i> Maximal testosterone suppression in the management of recurrent and metastatic prostate cancerLaurence Klotz, Rodney H Breau, Loretta L Collins, et al.
European Urology|June 30, 2009
Castration-resistant prostate cancer: from new pathophysiology to new treatment targetsKim N Chi, Anders Bjartell, David Dearnaley, et al.
Cellular Signalling|February 13, 2007
NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cellsLaurent Lessard, Fred Saad, Cécile Le Page, et al.
The Prostate|January 27, 2009
Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell linesBenjamin Péant, Jean-Simon Diallo, Florent Dufour, et al.
Pageof 113